Annual Drug Patent Expirations for QBRELIS
Qbrelis is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
Drug patent litigation for QBRELIS.
This drug has ten patent family members in eight countries.
The generic ingredient in QBRELIS is lisinopril. One supplier is listed for this compound. Additional details are available on the lisinopril profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
